• Neonatal Therapeutic Hypothermia in Ireland Annual Report | 2016-2017

      Meaney, S.; McGinley, J.; Horkan, S.; Corcoran, P.; Greene, R.A.; Murphy, J. (National Perinatal Epidemiology Centre, 2018-11)
      This report contains maternal and infant data pertaining to Neonatal Therapeutic Hypothermia (TH) in Ireland for the period of 2016/2017. Anonymised data was collected on maternal characteristics, history of antenatal care and delivery. Data were collected on infant characteristics, resuscitation, assessment, hospital transfers, their 72-hour clinical course, rewarming, feeding and outcomes.
    • Neonatal Therapeutic Hypothermia in Ireland: Annual Report: 2018 Aggregate Report 2016–2018

      Meaney, S.; McGinley, J.; Corcoran, P.; McKenna, P.; Filan, P.; Greene, R.A.; Murphy, J. (National Perinatal Epidemiology Centre, 2020-02)
      This is the Neonatal Therapeutic Hypothermia in Ireland report for 2018. It is a collaborative initiative undertaken by the National Clinical Programme for Paediatrics and Neonatology (NCPPN), the National Perinatal Epidemiology Centre (NPEC) and the National Women and Infants Health Programme (NWIHP). The Therapeutic Hypothermia steering committee has overseen the governance of the project. This report serves as a valuable resource to Medical, Midwifery and Nursing staff who are striving to make quality changes in the services we deliver to mothers and their babies. The recently formed National Neonatal Encephalopathy Action Group reflects this. The group comprises representatives from the Department of Health, the States Claims Agency, and the Health Service Executive, the NWIHP, the NPEC, Clinical Leads and patient advocates. The group acknowledges the long-lasting consequences caused by Neonatal Encephalopathy. The group aims to reduce avoidable instances of Neonatal Encephalopathy through the identification of known causes and risk factors and plans to drive initiatives to eliminate or mitigate them. The aspiration is a reduction in cases requiring therapeutic hypothermia intervention in our national maternity units/ hospitals. This working group has been endorsed by the Minister for Health Mr Simon Harris.
    • Neonatal Therapeutic Hypothermia in Ireland: Annual Report: 2019 Aggregate Report 2016-2019

      Meaney, S.; McGinley, J.; Corcoran, P.; McKenna, P.; Filan, P.; Greene, R.A.; Murphy, J. (National Perinatal Epidemiology Centre, 2021-04)
      This is the Neonatal Therapeutic Hypothermia report for 2019. The working partnership between the National Perinatal Epidemiology Centre, the National Women and Infant Health Programme and the National Clinical Programme for Paediatrics and Neonatology continues to be productive. This year marks the third published report. The Therapeutic Hypothermia (TH) steering committee continues to oversee the governance of this project and its members remain committed to the building of a national register for TH cases in Republic of Ireland. The electronic register was launched in early March 2020 and this system was utilised for the 2019 TH data collection. The data was collected and verified by the National TH Co-ordinator who visited the maternity units. The findings are accurate and applicable to clinical practice. This year, for the first time, data was collected on the Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) assessment of the infants. This developmental assessment is undertaken when the infant is aged two years. This assessment provides information on the longerterm outcome of the infant cohort.
    • Severe maternal morbidity in Ireland annual report 2019

      Leitao, S.; Manning, E.; Corcoran, P.; San Lazaro Campillo, I.; Greene, R.A. (National Perinatal Epidemiology Centre, 2021-04)
      The eighth report from the National Clinical Audit of Severe Maternal Morbidity (SMM) in Ireland reports on 375 cases of SMM occurring in all 19 Irish maternity units in 2019. The SMM rate is a composite rate of a group of clearly defined severe maternal morbidities. Over two thirds of the women who experienced SMM in 2019 were diagnosed with one morbidity (n=253, 67.5%); 25% (n=95) were diagnosed with two morbidities; 6% (n=24) with three SMMs; 0.5% (n=2) with four morbidities; and 0.3% (n=1) with five morbidities. The SMM rate has shown a steady increase since the reference year of 2011. From 2011 to 2019, the SMM rate has increased by 68% from 3.85 to 6.47 per 1,000 maternities. The incidence has changed from one case of SMM for every 260 maternities in 2011 to one case in 155 maternities in 2019.